Kuti, Joseph L <br/><br/>
Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenem.  [electronic resource] 

 -  Pharmacotherapy  Jul 2005 
 - 935-41 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0277-0008 
<br/><br/><label>Standard No.: </label>10.1592/phco.2005.25.7.935  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acinetobacter baumannii--drug effects<br/>Anti-Bacterial Agents--pharmacokinetics<br/>Ceftazidime--pharmacokinetics<br/>Clinical Trials as Topic<br/>Drug Resistance, Bacterial<br/>Escherichia coli--drug effects<br/>Female<br/>Gram-Negative Bacterial Infections--drug therapy<br/>Half-Life<br/>Humans<br/>Klebsiella pneumoniae--drug effects<br/>Male<br/>Meropenem<br/>Microbial Sensitivity Tests<br/>Monte Carlo Method<br/>North America<br/>Pseudomonas aeruginosa--drug effects<br/>Reference Values<br/>South America<br/>Thienamycins--pharmacokinetics